Key facts
- It has raised $1.2M across 1 recorded rounds; the latest was Seed Round ($815K) in Feb 2022.
- Notable investors include Expert DOJO, Arizona Commerce Authority.
- DataBiologics has filed 2 Form Ds with the SEC since 2023, most recently Sep 2025 ($815K sold to 16 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for DataBiologics
Funding rounds
1 roundsAbout DataBiologics
Operator of a regenerative medicine data collection platform intended for collecting patient-reported outcomes. The company's platform uses proprietary automation to collect valuable patient data and present real-time reports to make that data useful, enabling physicians to study the safety and efficacy of innovative treatments and make more informed decisions.
- Sector
- Healthcare
- HQ
- Gilbert, AZ, United States
- Founded
- 2018
- Employees
- 9
- Website
- databiologics.com/
- Ownership
- Privately Held (backing)
DataBiologics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DataBiologics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DataBiologics in its N-PORT filings yet. We sweep new filings monthly.